Related Experiment Video
Updated: Dec 28, 2025

08:52
3D Ultrasound Imaging: Fast and Cost-effective Morphometry of Musculoskeletal Tissue
Published on: November 27, 2017
23.8K
Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis
Akiko Nakano1, Hirotsugu Ohkubo2, Hiroyuki Taniguchi3
1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Scientific Reports
|February 13, 2020
Summary
Serial changes in erector spinae muscle cross-sectional area (ESMCSA) can predict survival in idiopathic pulmonary fibrosis (IPF) patients. An early decrease in ESMCSA is a significant prognostic factor for IPF survival.
Area of Science:
- Pulmonary Medicine
- Radiology
- Muscle Physiology
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options.
- Sarcopenia and cachexia are common in IPF and associated with poor outcomes.
- Computed tomography (CT) assessment of erector spinae muscle cross-sectional area (ESMCSA) is a potential tool for evaluating muscle wasting.
Purpose of the Study:
- To investigate the association between serial changes in ESMCSA and survival in patients with IPF.
- To determine if ESMCSA decline is an independent prognostic factor in IPF.
Main Methods:
- Retrospective review of CT images from 119 IPF patients.
- Measurement of ESMCSA at the 12th thoracic vertebra at baseline and 6-month follow-up.
- Survival analysis using Cox regression models.
Main Results:
- Univariate analysis identified declines in % predicted forced vital capacity (FVC), body mass index (BMI), and ESMCSA as prognostic factors.
- Multivariate analysis revealed that a decline in ESMCSA was a significant independent predictor of survival (HR 1.039, P=0.015).
- Declines in % FVC and BMI were not significant in multivariate analysis.
Conclusions:
- Early decrease in ESMCSA is a significant prognostic factor in patients with IPF.
- Serial CT assessment of ESMCSA may serve as a valuable tool for predicting survival in IPF.
- This finding could aid in risk stratification and clinical management of IPF patients.

